Publications by authors named "Tom Tencer"

Claim this Profile
H
Healthcare Resource Utilization and Costs Associated With Eosinophilic Esophagitis Among Commercially Insured Patients in the United States.
Qian Xia, Tom Tencer, Greeta Jobson, Ellen Qian, Evan S Dellon

Am J Gastroenterol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Systematic Review of the Economic and Health-Related Quality of Life Impact of Advanced Therapies Used to Treat Moderate-to-Severe Ulcerative Colitis.
Allie Cichewicz, Tom Tencer, Komal Gupte-Singh, Sonya Egodage, Heather Burnett

Adv Ther· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative efficacy and safety of ozanimod and ponesimod for relapsing multiple sclerosis: A matching-adjusted indirect comparison.
Elyse Swallow, Timothy Pham, Oscar Patterson-Lomba, Lei Yin, Andres Gomez-Lievano, Tom Tencer

Mult Scler Relat Disord· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic Literature Review of Real-World Evidence on Dose Escalation and Treatment Switching in Ulcerative Colitis.
Harpreet Singh, Liam Wilson, Tom Tencer, Jinender Kumar

Clinicoecon Outcomes Res· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endoscopic mucosal healing and histologic remission in ulcerative colitis: a systematic literature review of clinical, quality-of-life and economic outcomes.
Anuja Pandey, Lea Achrafie, Petya Kodjamanova, Tom Tencer, Jinender Kumar

Curr Med Res Opin· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient and neurologist preferences in the UK for relapsing-remitting multiple sclerosis treatments: findings from a discrete choice experiment.
Tom Tencer, Oliver Will, Jinender Kumar, M Janelle Cambron-Mellott, deMauri S Mackie

Curr Med Res Opin· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Efficacy and Safety of Ozanimod and Dimethyl Fumarate for Relapsing-Remitting Multiple Sclerosis Using Matching-Adjusted Indirect Comparison.
Stanley Cohan, Jinender Kumar, Stella Arndorfer, Xuelian Zhu, Marko Zivkovic, Tom Tencer

CNS Drugs· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Matching-adjusted indirect treatment comparison of ozanimod versus teriflunomide for relapsing multiple sclerosis.
Stanley Cohan, Tom Tencer, Stella Arndorfer, Xuelian Zhu, Marko Zivkovic

Mult Scler Relat Disord· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient and Neurologist Preferences in the United States for Relapsing-Remitting Multiple Sclerosis Treatments: Findings from a Discrete Choice Experiment.
Jinender Kumar, M Janelle Cambron-Mellott, Tom Tencer, Oliver Will, deMauri S Mackie

Patient Prefer Adherence· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of the Functional Assessment of Cancer Therapy--anemia in persons with myeloproliferative neoplasm-associated myelofibrosis and anemia.
Ayalew Tefferi, Stacie Hudgens, Ruben Mesa, Robert Peter Gale, Srdan Verstovsek, Tom Tencer

Clin Ther· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis